vs
Side-by-side financial comparison of EQUITY BANCSHARES INC (EQBK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $63.5M, roughly 1.2× EQUITY BANCSHARES INC). On growth, EQUITY BANCSHARES INC posted the faster year-over-year revenue change (28.4% vs 27.7%). EQUITY BANCSHARES INC produced more free cash flow last quarter ($38.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.6%).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
EQBK vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.5M | $75.5M |
| Net Profit | $22.1M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 41.7% | 22.7% |
| Net Margin | 34.8% | — |
| Revenue YoY | 28.4% | 27.7% |
| Net Profit YoY | 30.0% | — |
| EPS (diluted) | $1.07 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $63.5M | $75.5M | ||
| Q3 25 | $18.0M | $54.5M | ||
| Q2 25 | $58.4M | $52.4M | ||
| Q1 25 | $60.6M | $46.0M | ||
| Q4 24 | $58.3M | $59.1M | ||
| Q3 24 | $55.3M | $80.5M | ||
| Q2 24 | $55.4M | $47.1M | ||
| Q1 24 | $55.9M | $43.8M |
| Q4 25 | $22.1M | — | ||
| Q3 25 | $-29.7M | $8.8M | ||
| Q2 25 | $15.3M | $5.9M | ||
| Q1 25 | $15.0M | $3.0M | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $19.9M | $20.3M | ||
| Q2 24 | $11.7M | $-4.5M | ||
| Q1 24 | $14.1M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 41.7% | 22.7% | ||
| Q3 25 | -207.2% | 17.6% | ||
| Q2 25 | 31.5% | 12.7% | ||
| Q1 25 | 31.1% | 8.7% | ||
| Q4 24 | 35.0% | 22.6% | ||
| Q3 24 | 43.1% | 27.4% | ||
| Q2 24 | 29.4% | -4.6% | ||
| Q1 24 | 31.8% | -5.3% |
| Q4 25 | 34.8% | — | ||
| Q3 25 | -164.7% | 16.2% | ||
| Q2 25 | 26.1% | 11.2% | ||
| Q1 25 | 24.8% | 6.5% | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 35.9% | 25.2% | ||
| Q2 24 | 21.1% | -9.6% | ||
| Q1 24 | 25.2% | -11.0% |
| Q4 25 | $1.07 | $0.26 | ||
| Q3 25 | $-1.55 | $0.17 | ||
| Q2 25 | $0.86 | $0.12 | ||
| Q1 25 | $0.85 | $0.06 | ||
| Q4 24 | $1.06 | $0.40 | ||
| Q3 24 | $1.28 | $0.41 | ||
| Q2 24 | $0.76 | $-0.09 | ||
| Q1 24 | $0.90 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $443.2M | $22.7M |
| Stockholders' EquityBook value | $732.1M | $130.3M |
| Total Assets | $6.4B | $216.3M |
| Debt / EquityLower = less leverage | 0.61× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $443.2M | $22.7M | ||
| Q3 25 | $486.9M | $34.0M | ||
| Q2 25 | $448.4M | $45.3M | ||
| Q1 25 | $376.9M | $56.7M | ||
| Q4 24 | $312.8M | $68.0M | ||
| Q3 24 | $437.5M | $79.3M | ||
| Q2 24 | $391.7M | $90.7M | ||
| Q1 24 | $367.1M | $102.0M |
| Q4 25 | $732.1M | $130.3M | ||
| Q3 25 | $711.9M | $115.3M | ||
| Q2 25 | $635.6M | $104.7M | ||
| Q1 25 | $617.3M | $97.1M | ||
| Q4 24 | $592.9M | $92.1M | ||
| Q3 24 | $504.0M | $71.1M | ||
| Q2 24 | $461.4M | $48.5M | ||
| Q1 24 | $456.8M | $51.0M |
| Q4 25 | $6.4B | $216.3M | ||
| Q3 25 | $6.4B | $202.9M | ||
| Q2 25 | $5.4B | $194.9M | ||
| Q1 25 | $5.4B | $196.2M | ||
| Q4 24 | $5.3B | $213.3M | ||
| Q3 24 | $5.4B | $220.7M | ||
| Q2 24 | $5.2B | $205.0M | ||
| Q1 24 | $5.2B | $214.1M |
| Q4 25 | 0.61× | 0.17× | ||
| Q3 25 | 0.68× | 0.30× | ||
| Q2 25 | 0.71× | 0.43× | ||
| Q1 25 | 0.61× | 0.58× | ||
| Q4 24 | 0.53× | 0.74× | ||
| Q3 24 | 0.87× | 1.12× | ||
| Q2 24 | 0.85× | 1.87× | ||
| Q1 24 | 0.80× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $51.4M | $14.4M |
| Free Cash FlowOCF − Capex | $38.1M | $14.4M |
| FCF MarginFCF / Revenue | 60.0% | 19.1% |
| Capex IntensityCapex / Revenue | 20.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $88.8M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.4M | $14.4M | ||
| Q3 25 | $8.5M | $9.7M | ||
| Q2 25 | $28.3M | $14.1M | ||
| Q1 25 | $21.7M | $3.6M | ||
| Q4 24 | $73.8M | $15.6M | ||
| Q3 24 | $23.5M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M | ||
| Q1 24 | $12.6M | $11.2M |
| Q4 25 | $38.1M | $14.4M | ||
| Q3 25 | $4.5M | $9.7M | ||
| Q2 25 | $26.0M | $14.1M | ||
| Q1 25 | $20.2M | $3.6M | ||
| Q4 24 | $65.4M | $15.6M | ||
| Q3 24 | $19.7M | $11.0M | ||
| Q2 24 | $15.2M | $1.0M | ||
| Q1 24 | $10.6M | — |
| Q4 25 | 60.0% | 19.1% | ||
| Q3 25 | 24.7% | 17.7% | ||
| Q2 25 | 44.5% | 26.8% | ||
| Q1 25 | 33.3% | 7.7% | ||
| Q4 24 | 112.1% | 26.4% | ||
| Q3 24 | 35.6% | 13.7% | ||
| Q2 24 | 27.4% | 2.1% | ||
| Q1 24 | 19.0% | — |
| Q4 25 | 20.9% | 0.0% | ||
| Q3 25 | 22.3% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 14.6% | 0.0% | ||
| Q3 24 | 6.8% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 3.6% | 0.0% |
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 1.85× | 2.41× | ||
| Q1 25 | 1.44× | 1.21× | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | 0.54× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
